Afshana Quadiri

This paper develops a multi-epitope vaccine targeting conserved B- and T-cell epitopes from SARS-CoV-2, showing protection against Delta and Omicron variants in a mouse model.

This study shows that CXCL13 deficiency in mice worsens SARS-CoV-2 infection, with higher viral load, lung damage, and reduced B and T cell responses.

This study tests a prime/pull/keep HSV-1 vaccine in HLA-A*0201 transgenic rabbits, showing it reduces corneal herpes infection by mobilizing and retaining CD8+ T cells in infected tissues.

This study identifies conserved B-cell epitopes on the SARS-CoV-2 Spike protein that elicit strong neutralizing antibodies and provide protection against the Delta variant in a mouse model.

This study shows that a specific lipid nanoparticle formulation enhances B- and T-cell responses and provides better protection against SARS-CoV-2 in hamsters.

This study shows that a prime/pull vaccine using HSV-2 RR2 protein and CXCL11 chemokine boosts CD4+ and CD8+ T cells in DRG and VM tissues, reducing recurrent genital herpes severity and frequency.

This paper develops a multi-antigen mRNA/LNP-based pan-CoV vaccine that provides cross-protective immunity against multiple SARS-CoV-2 variants in a hamster model.